Cell penetrable human scFvs (transbodies) to Ebolavirus (EBOV) VP40 were produced.
The transbodies inhibited egress of EBOV-like particles (VLPs) from human hepatocytes.
They interacted with VP40 CTD basic residues important for plasma membrane binding.
And hence interfere with viral matrix assembly and viral progeny budding.
This is the first report on human antibodies that target intracellular EBOV VP40.